A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1

Overview of attention for article published in Lipids in Health and Disease, June 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,011 followers.

RT @Centogene: The results of a study published 28 June using CENTOGENE’s Lyso-SM509 biomarker for treatment monitoring demonstrated that t…

17 Jul 2019

Reply Repost Favourite

RT @Centogene: The results of a study published 28 June using CENTOGENE’s Lyso-SM509 biomarker for treatment monitoring demonstrated that t…

15 Jul 2019

Reply Repost Favourite

The results of a study published 28 June using CENTOGENE’s Lyso-SM509 biomarker for treatment monitoring demonstrated that that the progress of #niemannpick disease type C1 can be halted and blocked at the molecular level. For more information: https://t.c

15 Jul 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.